We are live on ! Find out more
CC

Cannell & Co Portfolio holdings

AUM $3.15B
1-Year Est. Return 30.62%
This Fund
S&P 500
This Quarter Est. Return
+6.41%
1 Year Est. Return
+30.62%
3 Year Est. Return
+51.59%
5 Year Est. Return
+187.25%
10 Year Est. Return
+311.51%
AUM
$2.83B
AUM Growth
+$152M
Cap. Flow
+$15.2M
Cap. Flow %
0.54%
Top 10 Hldgs %
26.33%
Holding
271
New
16
Increased
59
Reduced
91
Closed
20

Top Sells

Rank Stock Value
1
ZBH icon
Zimmer Biomet
ZBH
+$33.1M
2
HDS
HD Supply Holdings, Inc.
HDS
+$27.2M
3
LEN icon
Lennar Class A
LEN
+$24M
4
TJX icon
TJX Companies
TJX
+$14.1M
5
NKE icon
Nike
NKE
+$10.8M

Sector Composition

Rank Sector Weight
1 Healthcare 18.28%
2 Technology 17.4%
3 Industrials 13.24%
4 Consumer Discretionary 12.14%
5 Financials 12.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TEUM
201
DELISTED
Pareteum Corporation
TEUM
$521K 0.02%
173,665
BP icon
202
BP
BP
$113B
$519K 0.02%
11,783
-170
-1% -$7.11K
CSTM icon
203
Constellium
CSTM
$3.96B
$515K 0.02%
41,725
+7,600
+22% +$88.9K
ET icon
204
Energy Transfer Partners
ET
$70.1B
$502K 0.02%
28,800
ED icon
205
Consolidated Edison
ED
$41.6B
$478K 0.02%
6,268
KMI icon
206
Kinder Morgan
KMI
$73.1B
$467K 0.02%
26,344
GG
207
DELISTED
Goldcorp Inc
GG
$457K 0.02%
44,770
AON icon
208
Aon
AON
$77.3B
$450K 0.02%
2,925
EOG icon
209
EOG Resources
EOG
$78B
$430K 0.02%
3,373
+263
+8% +$32K
CXO
210
DELISTED
CONCHO RESOURCES INC.
CXO
$429K 0.02%
2,807
+190
+7% +$26.8K
MCS icon
211
Marcus Corp
MCS
$732M
$425K 0.02%
10,100
MACK
212
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$402K 0.01%
95,791
DD icon
213
DuPont de Nemours
DD
$18.6B
$394K 0.01%
2,419
+62
+3% +$10.7K
VLY icon
214
Valley National Bancorp
VLY
$7.93B
$394K 0.01%
35,000
AMID
215
DELISTED
American Midstream Partners, LP
AMID
$389K 0.01%
61,200
WTRG icon
216
Essential Utilities
WTRG
$11.2B
$370K 0.01%
10,039
-836
-8% -$30.9K
HES
217
DELISTED
Hess
HES
$365K 0.01%
5,100
AVHI
218
DELISTED
A V Homes, Inc.
AVHI
$353K 0.01%
17,662
CELGZ
219
DELISTED
Celgene Corporation Contingent Value Rights
CELGZ
$351K 0.01%
219,283
-114,582
-34% -$152K
OEF icon
220
iShares S&P 100 ETF
OEF
$19.8B
$335K 0.01%
2,582
+2
+0.1% +$253
ORCL icon
221
Oracle
ORCL
$331B
$322K 0.01%
6,250
SMPL icon
222
Simply Good Foods
SMPL
$904M
$311K 0.01%
16,000
+1,000
+7% +$17.4K
VRTX icon
223
Vertex Pharmaceuticals
VRTX
$121B
$296K 0.01%
1,538
CGNX icon
224
Cognex
CGNX
$10.3B
$279K 0.01%
5,000
CVS icon
225
CVS Health
CVS
$137B
$264K 0.01%
3,350

Similar funds

Cannell & Co's Q3 2018 Portfolio in Review

As of Q3 2018, Cannell & Co held 271 positions worth $2.83B, up 5.7% from $2.67B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Cannell & Co's Q3 2018 filing shows 16 new, 59 increased, 91 reduced and 20 closed positions. Its largest new stake was KKR & Co: 1,712,525 shares worth $46.7M. The largest sale was Zimmer Biomet, an estimated $33.1M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.

  • Cannell & Co's largest Q3 2018 buy was KKR & Co: 1,712,525 shares worth $46.7M.
  • Cannell & Co added most to Lowe's Companies in Q3 2018, an estimated $44.9M increase.
  • Cannell & Co's biggest Q3 2018 reduction was Zimmer Biomet, cutting an estimated $33.1M.
  • Cannell & Co fully exited SUPERVALU Inc. in Q3 2018, selling an estimated $10.4M.
  • Cannell & Co's ten largest holdings make up 26% of its $2.83B portfolio in Q3 2018.
  • Cannell & Co opened 16 new positions and closed 20 in Q3 2018.
  • Cannell & Co's portfolio value rose 5.7% quarter-over-quarter to $2.83B.

Based on Cannell & Co's 13F filing for Q3 2018, filed 5 Nov 2018.